Ketamine's Effects on Sleep in Mood Disorders: A Review

Understanding Ketamine's Role in Mood Disorders

Recent research published on May 6, 2026, in PubMed examines the effects of ketamine on sleep and circadian rhythms in patients with major depressive disorder (MDD) and bipolar disorder (BD). This systematic review provides a comprehensive overview of how ketamine, a dissociative anesthetic known for its rapid antidepressant effects, influences sleep patterns in these populations.

Mechanisms and Context

Ketamine is primarily known for its ability to provide rapid relief from depressive symptoms, often within hours of administration. However, its impact on sleep and circadian rhythms has been less clear. The review highlights that while ketamine can disrupt sleep architecture, it may also normalize certain aspects of circadian rhythms that are often disturbed in mood disorders. This dual effect underscores the complexity of ketamine's action on the brain.

Implications for Clinical Practice

The findings from this review could significantly inform clinical guidelines. Understanding ketamine's impact on sleep is crucial for optimizing treatment protocols. Clinicians may need to weigh the benefits of its antidepressant effects against potential disruptions in sleep, tailoring treatment plans to individual patient needs. This could lead to more personalized and effective interventions for those suffering from mood disorders.

Risks and Unknowns

Despite its potential benefits, the use of ketamine is not without risks. Sleep disturbances could exacerbate symptoms in some patients, leading to a complex interplay between treatment efficacy and side effects. Moreover, the long-term effects of ketamine on sleep and overall mental health remain largely unknown, necessitating further research to fully understand its implications.

Looking Ahead

Future research should focus on the long-term impacts of ketamine on sleep and circadian rhythms, particularly in diverse patient populations. As the use of ketamine expands in clinical settings, ongoing studies will be critical to refining treatment protocols and ensuring patient safety. This systematic review lays the groundwork for such investigations, highlighting the need for a nuanced approach to ketamine therapy in mood disorders.